231 related articles for article (PubMed ID: 33709495)
1. Efficacy and cost-effectivity analysis of outpatient parenteral antimicrobial therapy unit in infectious disease clinical practices: Turkey perspective.
Bastug A; Oksuz E; Kazancioglu S; Malhan S; Ozbay BO; Bodur H
Int J Clin Pract; 2021 Jun; 75(6):e14147. PubMed ID: 33709495
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
[TBL] [Abstract][Full Text] [Related]
3. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
[TBL] [Abstract][Full Text] [Related]
4. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
Conant MM; Erdman SM; Osterholzer D
J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.
Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD
J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623
[TBL] [Abstract][Full Text] [Related]
6. Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications.
Connors WJ; Rabie HH; Figueiredo RL; Holton DL; Parkins MD
BMC Infect Dis; 2017 Mar; 17(1):202. PubMed ID: 28279155
[TBL] [Abstract][Full Text] [Related]
7. Review of the first comprehensive outpatient parenteral antimicrobial therapy program in a tertiary care hospital in Japan.
Hase R; Yokoyama Y; Suzuki H; Uno S; Mikawa T; Suzuki D; Muranaka K; Hosokawa N
Int J Infect Dis; 2020 Jun; 95():210-215. PubMed ID: 32205285
[TBL] [Abstract][Full Text] [Related]
8. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
[TBL] [Abstract][Full Text] [Related]
9. Impact of an outpatient parenteral antimicrobial treatment (OPAT) as part of a paediatric-specific PROA program.
Fernández-Polo A; Ramon-Cortes S; Plaja-Dorca J; Bartolomé-Comas R; Vidal-Valdivia L; Soler-Palacín P;
Enferm Infecc Microbiol Clin (Engl Ed); 2023 Apr; 41(4):230-234. PubMed ID: 35961853
[TBL] [Abstract][Full Text] [Related]
10. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses.
Dimitrova M; Gilchrist M; Seaton RA
BMJ Open; 2021 Sep; 11(9):e049733. PubMed ID: 34588251
[TBL] [Abstract][Full Text] [Related]
11. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system.
Psaltikidis EM; Silva END; Moretti ML; Trabasso P; Stucchi RSB; Aoki FH; Cardoso LGO; Höfling CC; Bachur LF; Ponchet DDF; Colombrini MRC; Tozzi CS; Ramos RF; Costa SMQ; Resende MR
Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):341-352. PubMed ID: 30362845
[TBL] [Abstract][Full Text] [Related]
12. Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis.
Adams JW; Savinkina A; Hudspeth JC; Gai MJ; Jawa R; Marks LR; Linas BP; Hill A; Flood J; Kimmel S; Barocas JA
JAMA Netw Open; 2022 Feb; 5(2):e220541. PubMed ID: 35226078
[TBL] [Abstract][Full Text] [Related]
13. Discharge Delays and Costs Associated With Outpatient Parenteral Antimicrobial Therapy for High-Priced Antibiotics.
Bianchini ML; Kenney RM; Lentz R; Zervos M; Malhotra M; Davis SL
Clin Infect Dis; 2020 Oct; 71(7):e88-e93. PubMed ID: 31665269
[TBL] [Abstract][Full Text] [Related]
14. Outpatient parenteral antimicrobial therapy for infective endocarditis: a cost-effective strategy.
Lacroix A; Revest M; Patrat-Delon S; Lemaître F; Donal E; Lorléac'h A; Arvieux C; Michelet C; Tattevin P
Med Mal Infect; 2014 Jul; 44(7):327-30. PubMed ID: 25022891
[TBL] [Abstract][Full Text] [Related]
15. Infectious Diseases Specialty Intervention Is Associated With Better Outcomes Among Privately Insured Individuals Receiving Outpatient Parenteral Antimicrobial Therapy.
Shah A; Petrak R; Fliegelman R; Shrestha N; Allison G; Zurlo J; Parker S; Poretz D; McKinsey D; Dougherty M; Martinelli L; Mathur A; Rodriguez A; Smith MW
Clin Infect Dis; 2019 Mar; 68(7):1160-1165. PubMed ID: 30247512
[TBL] [Abstract][Full Text] [Related]
16. Clinical benefits and costs of an outpatient parenteral antimicrobial therapy service.
Bugeja SJ; Stewart D; Vosper H
Res Social Adm Pharm; 2021 Oct; 17(10):1758-1763. PubMed ID: 33551209
[TBL] [Abstract][Full Text] [Related]
17. Outpatient parenteral antibiotic therapy (OPAT) and inpatient treatment strategies for emergency department patients with cellulitis: a cost analysis.
Yadav K; Kumar S; Chhabra S; Rosenberg H; Eagles D; Suh KN; Ohle R; Nath A; Thavorn K
CJEM; 2022 Aug; 24(5):520-528. PubMed ID: 35675027
[TBL] [Abstract][Full Text] [Related]
18. Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study.
Sumpter C; Russell CD; Mackintosh C
Int J Equity Health; 2020 Sep; 19(1):150. PubMed ID: 32873291
[TBL] [Abstract][Full Text] [Related]
19. Outpatient Versus Inpatient Intravenous Antimicrobial Therapy: A Population-Based Observational Cohort Study of Adverse Events and Costs.
Staples JA; Ho M; Ferris D; Hayek J; Liu G; Tran KC; Sutherland JM
Clin Infect Dis; 2022 Nov; 75(11):1921-1929. PubMed ID: 35439822
[TBL] [Abstract][Full Text] [Related]
20. Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States.
Karimaghaei S; Rao A; Chijioke J; Finch N; Nigo M
J Clin Pharm Ther; 2022 Feb; 47(2):211-217. PubMed ID: 34699089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
